Q4 2024 Earnings Call Transcript March 25, 2025 X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line ...

In the assessment of 12-month price targets, analysts unveil insights for X4 Pharmaceuticals, presenting an average target of ...

Reports Q4 revenue $1.4M vs. $0 last year. “As expected, 2024 was a transformative year for the company and our momentum has continued into ...

GameSir X4 Aileron: one-minute review. T he GameSir X4 Aileron is a mobile controller purpose-built for cloud gaming on an Android phone, turning your device into a glorified hand ...

X4 Pharmaceuticals Inc (XFOR) navigates a challenging landscape with strategic cost reductions and promising product ...

X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...

If you buy something via one of our links, we may earn a commission. As a massive fan of the Insta360 X3, I was thrilled when a brand-new X4 arrived at my doorstep for testing earlier this season. The ...

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.

While its more formal, upright X3 sibling is all-new for the 2025 model year, the fastback BMW X4 soldiers on basically unchanged for another year. The only updates BMW is making to the compact ...

The latest price target for X4 Pharmaceuticals (NASDAQ:XFOR) was reported by HC Wainwright & Co. on March 27, 2025. The analyst firm set a price target for $1.50 expecting XFOR to rise to within ...

SALT LAKE CITY — Before thousands of people flock to downtown Salt Lake City to attend the Qualtrics X4 summit, the Provo-born company on Tuesday unveiled its next move toward delivering the ...